Overview

Cepheid manufactures integrated molecular diagnostic systems and tests for infectious diseases, oncology, and genetics. Headquartered in Sunnyvale, California, and founded in 1996, the company employs 1,000–5,000 people and reports approximately $900 million in revenue. A wholly owned subsidiary of Danaher Corporation since 2016, Cepheid serves medical laboratories and clinical customers across 17 countries. In September 2026, the World Health Organization granted emergency use listing for its Xpert Hemorrhagic Fever Panel Test to support Ebola outbreak response efforts in the Democratic Republic of Congo.

At a glance

What Cepheid makes

The company manufactures the GeneXpert System, a fully automated molecular platform that performs sample preparation, DNA amplification, and detection, and holds ISO 13485 certification for medical device quality management.

Certifications

Cepheid is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

• ISO 13485 — mtender.gov.md

Latest developments

• 2026-11-03 — Cepheid Receives FDA Clearance for Xpert® Hemorrhagic Fever Panel Test (prnewswire.com)

• 2026-10-08 — TCHD Seeks Cepheid Molecular Reagent Agreement Extension (civiciq.com)

• 2026-09-03 — WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC - Sep 3, 2026 (mediaroom.com)

• 2026-06-18 — Lodi's largest private employer expands with fifth building - Sacramento Business Journal (bizjournals.com)

• 2026-05-30 — Cepheid: Lodi’s Largest Private Employer Is Also One of the World’s Most Important Medical Companies — Lodi 411 (lodi411.com)

• 2026-04-15 — Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration - Apr 15, 2026 (mediaroom.com)

Facilities

Cepheid is headquartered in Sunnyvale, California. Public sources also reference these locations:

• Bangalore, India — cepheid.com

Company details

Cepheid operates facilities in Bangalore, India, and maintains a presence across 17 countries as a subsidiary of Danaher Corporation. Cepheid was founded in 1996, has an estimated 1,000-5,000 employees, and is headquartered in Sunnyvale, California. On the LightSource stability read it is rated "Established & strong": 30 years in operation (founded 1996). Publicly listed; no distress event on record. Holds ISO 13485 certification(s) per public sources.

Frequently asked questions

What does Cepheid make?

Cepheid manufactures integrated molecular diagnostic systems and tests for infectious diseases, oncology, and genetics. Headquartered in Sunnyvale, California, and founded in 1996, the company employs 1,000–5,000 people and reports approximately $900 million in revenue. A wholly owned subsidiary of Danaher Corporation since 2016, Cepheid serves medical laboratories and clinical customers across 17 countries. In September 2026, the World Health Organization granted emergency use listing for its Xpert Hemorrhagic Fever Panel Test to support Ebola outbreak response efforts in the Democratic Republic of Congo.

Where is Cepheid headquartered?

Cepheid is headquartered in Sunnyvale, California (904 East Caribbean Drive, Sunnyvale, California, 94089).

When was Cepheid founded?

Cepheid was founded in 1996.

How big is Cepheid?

Cepheid has an estimated 1,000-5,000 employees, with revenue in the 900M range.

Is Cepheid publicly traded?

Publicly traded (NASDAQ: CPHD). Public financial figures are drawn from its filings.

What certifications does Cepheid hold?

Cepheid lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.

Related suppliers

Explore other suppliers in the LightSource directory:

• 10xEngineers

• 1X

• 365 Retail Markets

• 3Com

• 3PAR

Last verified Nov 2026. Is this your company? Request a correction.